logo
Plus   Neg
Share
Email

Walmart Introduces First-of-its-kind Centers Of Excellence Program

Wal-Mart Stores Inc. (WMT) said it is introducing a first-of-its-kind Centers of Excellence program that will offer its associates quality health care with no out-of-pocket cost for heart, spine, and transplant surgeries at six of the leading hospital and health systems in the U.S.

The six designated health care organizations include the Cleveland Clinic in Cleveland, Ohio; Geisinger Medical Center in Danville, Pa.; Mayo Clinic sites in Rochester, Minn., Scottsdale/Phoenix, Ariz., and Jacksonville, Fla.; Mercy Hospital Springfield in Springfield, Mo; Scott & White Memorial Hospital in Temple, Texas; and Virginia Mason Medical Center in Seattle, Wash. These organizations will give Walmart associates the opportunity to receive care at hospitals and medical centers geographically located across the country that specialize in heart, spine and transplant care.

The new Centers of Excellence program is being expanded from covering transplants, which began with the Mayo Clinic in 1996, to include treatment for certain heart and spine surgeries. Walmart's associates and their dependents who are enrolled in the company's medical plans will receive consultations and care covered at 100 percent without deductible or coinsurance, plus travel, lodging and food for the patient and a caregiver.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walmart Inc. has launched a nationwide drive to boost COVID-19 vaccination rates by reaching out to more residents in vulnerable communities. The retail giant will organize a series of community events at 43 locations in 18 states to administer the COVID-19 vaccine. Walmart said it plans to continue these new events over the next several weeks as vaccine allocations allow. Pfizer Inc. (PFE) and OPKO Health Inc. (OPK) announced Friday that the European Medicines Agency or EMA has validated for review the Marketing Authorization Application for somatrogon. Pfizer expects a decision from the European Commission in 2022. The company said somatrogon is a long-acting recombinant... German telecom giant Deutsche Telekom AG reported Friday strong growth in fourth-quarter profit mainly driven by T-Mobile US results following the takeover of the competitor Sprint. Looking ahead for fiscal 2021, the company projects higher adjusted EBITDA AL, a key earnings metric.
Follow RTT